New York State Common Retirement Fund Eledon Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 4,200 shares of ELDN stock, worth $7,392. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,200
Previous 36,400
88.46%
Holding current value
$7,392
Previous $98,000
89.8%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ELDN
# of Institutions
94Shares Held
39MCall Options Held
31.2KPut Options Held
157K-
Bvf Inc San Francisco, CA6.29MShares$11.1 Million0.88% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$6.28 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$5.75 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY2.07MShares$3.65 Million0.21% of portfolio
-
Zimmer Partners, LP New York, NY1.83MShares$3.21 Million0.13% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $24.2M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...